Mesoblast (MESO) Other Working Capital Changes (2016 - 2023)

Mesoblast (MESO) posted quarterly Other Working Capital Changes of -$682000.0 for Q1 2023, up 40.44% year-on-year from -$485628.1 in Q1 2022, and down 55.35% on a QoQ basis from -$439000.0 in Q4 2022.

Mesoblast (MESO) Other Working Capital Changes (2016 - 2023) Analysis & Trends

Mesoblast (MESO) has reported Other Working Capital Changes for 8 consecutive years, with -$682000.0 the latest figure, recorded in Q1 2023.

  • Quarterly Other Working Capital Changes rose 40.44% year-over-year to -$682000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was -$2.2 million (up 30.41% YoY) and the FY2022 annual result came in at -$2.8 million, up 4.88% from the prior year.
  • Other Working Capital Changes retreated to -$682000.0 in Q1 2023 per MESO's latest filing, from -$439000.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for MESO reached as high as $2.4 million in Q1 2022 and fell as low as -$3.3 million in Q4 2021.
  • A 5-year average of $294750.0 and a median of $1.0 million in 2020 frame the typical range for Other Working Capital Changes.
  • Annual changes were most pronounced in 2020 — Other Working Capital Changes plunged 1084.48% — and 2021, when it surged 86.77%.
  • Year by year, Other Working Capital Changes stood at -$360000.0 in 2019, then slumped by 118.06% to -$785000.0 in 2020, then soared by 32.74% to -$528000.0 in 2021, then gained by 16.86% to -$439000.0 in 2022, then sank by 55.35% to -$682000.0 in 2023.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$682000.0, -$439000.0, and -$670000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Mesoblast 2.08 Bn 1.95 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2023 1.25 Mn
Mar 31, 2023 1.25 Mn
Mar 31, 2023 1.25 Mn
Dec 31, 2022 -1.77 Mn
Dec 31, 2022 -1.77 Mn
Dec 31, 2022 -1.77 Mn
Sep 30, 2022 1.34 Mn
Sep 30, 2022 1.34 Mn
Sep 30, 2022 1.34 Mn
Mar 31, 2022 2.39 Mn
Mar 31, 2022 2.39 Mn
Mar 31, 2022 2.39 Mn
Dec 31, 2021 -3.33 Mn
Dec 31, 2021 -3.33 Mn
Dec 31, 2021 -3.33 Mn
Sep 30, 2021 1.84 Mn
Sep 30, 2021 1.84 Mn
Sep 30, 2021 1.84 Mn
Sep 30, 2020 795,000.00
Sep 30, 2020 795,000.00